Assignee
GENFIT
FR61 patents
Top patents by PatentIndex Score
US7566737B2Jul 28, 2009
Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients
GENFIT23 citations91
US7375135B2May 20, 2008
Fatty acid derivatives; preparation and uses thereof
GENFIT39 citations86
US12053445B2Aug 6, 2024
Methods of treatment of cholestatic diseases
GENFIT7 citations84
US11857523B2Jan 2, 2024
Methods of treatment of cholestatic diseases
GENFIT7 citations84
US11850223B2Dec 26, 2023
Methods of treatment of cholestatic diseases
GENFIT7 citations84
US11331292B2May 17, 2022
Methods of treatment of cholestatic diseases
GENFIT13 citations84
US11185519B2Nov 30, 2021
Methods of treatment of cholestatic diseases
GENFIT15 citations84
US11590108B2Feb 28, 2023
Pharmaceutical compositions for combination therapy
GENFIT9 citations83
US7547729B2Jun 16, 2009
1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
GENFIT9 citations83
US7385082B2Jun 10, 2008
Preparation of 1,3-diphenylprop-2-en-1-one derivatives
GENFIT10 citations83
US11974997B2May 7, 2024
RORgamma modulators and uses thereof
GENFIT7 citations82
US11478440B2Oct 25, 2022
Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent
GENFIT10 citations82
US9585853B2Mar 7, 2017
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
GENFIT4 citations82
US9221751B2Dec 29, 2015
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
GENFIT9 citations82
US8895619B2Nov 25, 2014
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
GENFIT8 citations82
US7943661B2May 17, 2011
Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
GENFIT7 citations82
US7632870B2Dec 15, 2009
Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
GENFIT8 citations82
US11484517B2Nov 1, 2022
Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor
GENFIT10 citations81
US12310935B2May 27, 2025
Methods of treatment of cholestatic diseases
GENFIT1 citations73
US12303480B2May 20, 2025
Methods of treatment of cholestatic diseases
GENFIT1 citations73
US12295928B2May 13, 2025
Methods of treatment of cholestatic diseases
GENFIT2 citations73
US12295927B2May 13, 2025
Methods of treatment of cholestatic diseases
GENFIT1 citations73
US12290498B2May 6, 2025
Methods of treatment of cholestatic diseases
GENFIT1 citations73
US12233038B2Feb 25, 2025
Methods of treatment of cholestatic diseases
GENFIT1 citations73
US12053456B2Aug 6, 2024
Pharmaceutical compositions for combination therapy
GENFIT3 citations72
US10350181B2Jul 16, 2019
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
GENFIT2 citations71
US9782373B2Oct 10, 2017
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
GENFIT3 citations71
US11052092B2Jul 6, 2021
N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
GENFIT3 citations70
US11033534B2Jun 15, 2021
Pharmaceutical compositions for combination therapy
GENFIT3 citations70
US10653678B2May 19, 2020
Methods of treatment for cholestatic and fibrotic diseases
GENFIT3 citations70
US9902725B2Feb 27, 2018
Heterocyclic derivatives as RORgamma modulators
GENFIT4 citations68
US11676269B2Jun 13, 2023
Automated pattern recognition and scoring method of histological images
GENFIT3 citations63
US12208087B2Jan 28, 2025
Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation
GENFIT1 citations61
US11191749B2Dec 7, 2021
Pharmaceutical compositions for combination therapy
GENFIT1 citations60
US11103484B2Aug 31, 2021
Methods of treatment for cholestatic and fibrotic diseases
GENFIT0 citations60
US10905680B2Feb 2, 2021
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10130612B2Nov 20, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10130613B2Nov 20, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10117856B2Nov 6, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10117855B2Nov 6, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US11400078B2Aug 2, 2022
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations59
US11160801B2Nov 2, 2021
RORgamma modulators and uses thereof
GENFIT0 citations59
US12458612B2Nov 4, 2025
Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists
GENFIT0 citations58
US9115073B2Aug 25, 2015
1,3-diphenylpropane derivatives, preparations and uses thereof
GENFIT2 citations56
US12522564B2Jan 13, 2026
Polymorphs of elafibranor
GENFIT0 citations51
US12030840B2Jul 9, 2024
Elafibranor salts
GENFIT0 citations50
US10792277B2Oct 6, 2020
Methods of treatment of fibrosis and cancers
GENFIT0 citations50
US10722575B2Jul 28, 2020
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
GENFIT0 citations50
US10022343B2Jul 17, 2018
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
GENFIT0 citations50
US7253296B2Aug 7, 2007
Acylated aminopropanediols and analogues and therapeutic uses thereof
GENFIT1 citations50
Showing the top 50 of 61 patents by PatentIndex Score.